Related Experiment Videos

Angiocentric immunoproliferative lesion (lymphomatoid granulomatosis). A cytogenetic, immunophenotypic, and genotypic

L R Donner1, S Dobin, D Harrington

  • 1Department of Pathology, Scott and White Memorial Hospital, Temple, TX 76508.

Cancer
|January 15, 1990
PubMed

Insights

A cytogenetically abnormal clone was found in a patient with angiocentric immunoproliferative lesion (AIL). This discovery supports the idea that AIL is a neoplastic (cancerous) process.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Angiocentric immunoproliferative lesion (AIL), also known as lymphomatoid granulomatosis, is a rare condition.
  • Understanding the underlying biological mechanisms of AIL is crucial for diagnosis and treatment.

Observation:

  • A 23-year-old woman with a three-year history of AIL presented with involvement of skin, lungs, spleen, liver, and bone marrow.
  • Atypical lymphohistiocytic infiltrates were observed in these organs.

Findings:

  • Cytogenetic analysis of the spleen revealed an abnormal clone: 46,XX,t(1;6)(p35;q23),t(1;9;19)(q23;p24;q13).
  • Immunophenotypic study showed 46% of splenic cells had a helper/inducer T-cell phenotype.
  • Despite the T-cell phenotype, DNA analysis did not reveal clonal rearrangements in T-cell receptor or immunoglobulin genes.

Implications:

  • The identification of a cytogenetically abnormal clone provides strong evidence that AIL is a neoplastic process.
  • This finding may lead to new diagnostic criteria and therapeutic strategies for AIL.
  • Further research into the genetic basis of AIL is warranted.

Related Concept Videos